Impact Biomedical

Impact Biomedical Assets per Share

The Total Assets per Share of Impact Biomedical (IBO) as of Oct 17, 2026 is 0.16 USD. In the previous year, Total Assets per Share was 0.19 USD — a change of -14.22% (lower).

Assets per Share

0.16USD

YoY

-14.22%

Last updated:

Total Assets per Share of Impact Biomedical is 2025 0.16 USD. Total Assets per Share of Impact Biomedical was 2024 0.19 USD. It decreases by -14.22% lower compared to the previous year.

The Impact Biomedical Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
0.00 USD
Jan 1, 2019
0.00 USD
Jan 1, 2020
0.45 USD
Jan 1, 2021
0.52 USD
Jan 1, 2022
0.43 USD
Jan 1, 2023
0.41 USD
Jan 1, 2024
0.19 USD
Jan 1, 2025
0.16 USD
The Impact Biomedical Assets per Share history
YEARAssets per ShareYoY
0.16USD-14.22%
0.19USD-54.54%
0.41USD-4.01%
0.43USD-17.60%
0.52USD+17.33%
0.45USD+41,140.36%
0.00USD-46.31%
0.00USD-32.26%
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Impact Biomedical Stock analysis

What does Impact Biomedical do? Impact Biomedical Inc, headquartered in Houston, Texas, is a US-based healthcare company operating in the health care sector. The company, listed on 16 September 2024, employs one full-time employee and functions as a wholly owned subsidiary of DSS, Inc. Impact Biomedical focuses on advancing drug discovery and treatments for neurological, oncological, and immune-related diseases through its intellectual property and strategic investments. It also develops open-air defense initiatives targeting airborne infectious diseases like tuberculosis and influenza, alongside subsidiary Global BioLife, Inc., which researches projects including a universal therapeutic drug platform, a sugar substitute, and antimicrobial products. Impact Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Impact Biomedical stock

Total Assets per Share of Impact Biomedical is 0.16 USD in 2025.

Total Assets per Share of Impact Biomedical changed from 0.19 USD to 0.16 USD, representing a -14.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Impact Biomedical since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Impact Biomedical

All Key Metrics — Impact Biomedical